French drugmaker Sanofi plans to invest around €400 million annually in a center of excellence for mRNA vaccines that it hopes will accelerate the development and delivery of the next-generation vaccine portfolio it has built up in collaboration with US biotech Translate Bio. The company said the project will be “fully financed” through resource reallocation.
Celanese has emerged as the buyer of the TPV elastomers business Exxon Mobil put on the sale block earlier this year. The US chemicals and engineering plastics group said on Jun. 30 it had signed a definitive agreement to acquire the portfolio that includes the iconic Santoprene brand along with intellectual property, production and commercial assets.
French CDMO Novasep has announced plans to upgrade its API manufacturing facility in Mourenx, increasing its flexibility and competitiveness. The company will invest €6.1 million over three years and create seven full-time jobs.
AkzoNobel has agreed to purchase Colombia-based paints and coatings company Grupo Orbis, expanding its footprint in South and Central America. Financial terms of the deal, which is expected to close by the end of this year, were not revealed.
Lonza is investing 20 million Swiss francs in an expansion of its API development and manufacturing facility at Nansha, China. The Basel-based CDMO said the expanded laboratories and manufacturing infrastructure should be operational sometime between the first and the third quarter of next year. At the start, some 70 jobs will be added to the currently 250-member staff.
The US Food and Drug Administration (FDA) added information about myocarditis and pericarditis to its fact sheets for the mRNA-based Moderna and Pfizer/BioNTech Covid-19 vaccines on Jun. 25.
French gases group Air Liquide has announced plans to invest about €70 million in building a plant in Wuhan, China, to supply a major memory chipmaker, whose identity was not disclosed. Air Liquide will build, own and operate the ultra-high purity industrial gases plant, which will produce 52,000 Nm3/hr of nitrogen, as well as oxygen, argon and other gases. The facility is planned to be operational in 2022.
As part of its drive to reduce the complexity of its Consumer Healthcare (CHC) portfolio, French drugmaker Sanofi has agreed to sell 16 products marketed exclusively in Europe to German generics manufacturer Stada.
On June 10th, 2021, ten leading German corporations announced the foundation of the Quantum Technology and Application Consortium (QUTAC). Boosted by the German Government, the goal of the newly founded consortium is to further develop the existing fundamentals of quantum computing into usable industrial applications.
TotalEnergies has launched the e-CO2Met project that aims to produce methanol from green hydrogen. The French group is working on the project in Leuna, Germany, with electrolyzer manufacturer Sunfire, the Fraunhofer Center for Chemical-Biotechnological Processes and the Fraunhofer Institute for Microstructure of Materials and Systems IMWS.
Swiss CDMO Lonza is collaborating with Swedish pharma SelectImmune to develop processes for NlpD, a novel immunotherapy protein that could provide an alternative to antibiotics, given the increasing rise in resistance to antibacterial agents.
Catalent has announced plans to acquire RheinCell Therapeutics, a German developer and manufacturer of GMP-grade human induced pluripotent stem cells (iPSCs), a type of cell that can be differentiated into various cell types to address a wide range of therapeutic indications.
Dutch multinational storage operator Vopak has won a contract from China’s Huizhou QuanMei Petrochemical Terminal to build and operate a terminal as part of ExxonMobil’s proposed chemical complex at Huizhou.
Centrient Pharmaceuticals has started its expanded production of statins at its manufacturing plant for active pharmaceutical ingredients (APIs) in Toansa, India. With the start-up of its second unit at the site, the Dutch company said it has doubled capacity for Atorvastatin and Rosuvastatin, meeting the increased demand for its sustainably produced portfolio.
In a closely watched whistleblower suit, a federal court jury in the US state of Oregon has awarded $2.4 million to a former sales manager for AstraZeneca, who claimed the drugmaker fired her after she raised concerns of off-label marketing.
Global food giant Kerry Group has entered into an agreement to acquire Niacet Corp. from an affiliate of funds advised by private equity firm SK Capital Partners and other shareholders, for €853 million.
Brenntag is to buy US-based Storm Chaser Holding, also known as JM Swank, a leading distributor of food ingredients, in its third acquisition so far this year. The transaction is expected to close during the third quarter of 2021.
In what it called another “significant milestone” along the route to greener production globally, BASF has agreed to buy renewable electricity for its Zhanjiang integrated site in China from China Resources Power. The purchase transacted through the Guangdong Power Exchange Center was made possible by new government rules established in April, and BASF will be the first company to benefit.
US science and technology group Danaher has agreed to pay $9.6 billion to buy Aldevron, a compatriot contract developer and manufacturer of biologics for the pharmaceutical and biotechnology sectors.
Paris-headquartered engineering firm Technip Energies has agreed to cooperate with Agilyx Corporation on recycling of post-consumer polystyrene. The pact calls for the Technip group company to market and license the related technology of the two partners as an integrated package.
South Korea-based CDMO SK Bioscience, with cash in hand from an initial public offering, has announced plans to pour 150 billion won ($132 million) into vaccine production up to 2024, which will mean to adding some 99,130 m2 of production space and equipping its plant at Andong to make newer mRNA- and viral vector-based Covid-19 vaccines.
Distrupol, a UK-based distributor of thermoplastics and elastomers, has acquired Lautrup Chemicals, a Danish polymers distributor. Financial terms were not disclosed.
US paints and coatings company PPG has announced plans to expand its coatings capacity in Europe for packaging applications. The projects in the Netherlands and Poland will support growing customer demand for latest-generation coatings for aluminum and steel cans used to package beverage, food and personal care products.
In conjunction with its American Rescue Plan, the administration of US president Joe Biden has announced its intention to spend $3 billion on building a stockpile of pharmaceuticals that can be used to treat Covid-19 and other viral threats of the future.
Dutch multinational energy and chemicals group Shell will accelerate plans to reduce its greenhouse gas emissions following a Dutch legal ruling late last month.
The European Commission’s attempt to hold AstraZeneca (AZ) responsible for the delayed and truncated supply of its Covid-19 vaccine appears to have not produced the desired result, at least not in the first lawsuit to be heard.
AGC Biologics has agreed to supply plasmid DNA (pDNA) to Pfizer/BioNTech for their RNA-based Covid-19 vaccine. The biopharma CDMO based in Heidelberg, Germany, will manufacture the vaccine ingredient at its Heidelberg facility.
UK-based pharmatech Exscientia has entered into a binding agreement to buy Vienna-based Allcyte, a specialist in precision medicine using artificial intelligence (AI). Under the terms, Exscientia will pay €50 million, comprised of cash and Exscientia’s ordinary shares. The transaction is currently under review by Austrian regulators.
Just weeks after spending $60 million buying UK electro-chemical producer H.K. Wentworth, Element Solutions has offered to acquire Coventya, a French international manufacturer of specialty chemicals used in surface treatment, from private equity owner Silverfleet Capital.
In a stunning setback to the company’s ambitions of launching its mRNA-based Covid-19 vaccine in the third quarter, results from CureVac’s Phase 2b/3 trial showed the candidate branded CVnCoV to have an efficacy rate of only 47% against any severity of the disease.
An initial public offering for Wintershall Dea, the oil and gas producer owned by BASF and Letter One – last planned for the second half of 2021 – will not take place this year, the partners announced on Jun. 16, citing an uncertain market.
Evonik has entered into an agreement to buy Infinitec Activos, a privately owned Spanish company that specializes in the development and production of novel delivery systems for cosmetic active ingredients. Financial terms were not disclosed.
Flagship Pioneering, the venture capital fund behind US Covid vaccine manufacturer Moderna and other biotechs, said it has raised an additional $2.23 billion for its fund no. 7 launched in April 2020, bringing the total value to $3.37 billion. Simultaneously, Flagship has announced the appointment of former US Food and Drug Administration (FDA) commissioner Stephen Hahn to its management team as chief medical officer.
Dutch specialty chemicals company Nouryon has signed a 10-year agreement with Finland’s Metsä Fibre, a major producer of bioproducts, biochemicals and bioenergy, to supply sodium chlorate.
Dow is planning to build an integrated methylene diphenyl diisocyanate (MDI) distillation and prepolymers plant at its site in Freeport, Texas, USA, to support rising demand from the downstream polyurethane (PU) sector.
